Drug
D-2570 clinical trials
- studies test it
- 12
- open now
- 8
- in phase 3
- 1
- first study started
- 2024
Keep track of what changes. Save the D-2570 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- D-2570
- 10
Studies by the year they started
12 studies that test it; most in 2026 (7)
| Year | Studies |
|---|---|
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 6
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
Itraconazole (1) · Rifampin (1) · Omeprazole (1) · Midazolam (1) · Digoxin (1) · Rosuvastatin (1) · Metformin (1)
Studies
Open first, then newest update. How each study uses D-2570 is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsNot yet recruitingPhase 1InventisBio Co., LtdNCT07875842Written as D-2570
- The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function.RecruitingPhase 1InventisBio Co., LtdNCT07715175Written as D-2570
- A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic FunctionRecruitingPhase 1InventisBio Co., LtdNCT07715149Written as D-2570
- Study of D-2570 in Subjects With Non-Segmental VitiligoRecruitingPhase 2InventisBio Co., LtdNCT07625891Written as D-2570 Dose 1
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruitingPhase 2InventisBio Co., LtdNCT07489885Written as D-2570 Tablet
- A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)RecruitingPhase 2InventisBio Co., LtdNCT07311200Written as D-2570
- A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic ArthritisRecruitingPhase 2InventisBio Co., LtdNCT07315061Written as D-2570
- Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque PsoriasisRecruitingPhase 3InventisBio Co., LtdNCT07130604Written as D-2570
- Healthy Volunteer StudyActive, not recruitingPhase 1InventisBio Co., LtdNCT07270783Written as D-2570
- A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative ColitisActive, not recruitingPhase 2InventisBio Co., LtdNCT07035041Written as D-2570
- Single and Multiple Dose and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-2570 Tablets in Healthy SubjectsCompletedPhase 1InventisBio Co., LtdNCT07275775Written as D-2570
- Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque PsoriasisCompletedPhase 2InventisBio Co., LtdNCT06278350Written as D-2570